Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Avacta Group plc
Industry Sector: CommercialServices
CEO: Christina Marie Coughlin, MD, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -3.89
Exchange/Ticker 1: LSE:AVCT
Exchange/Ticker 2: N/A
Latest Market Cap: $165,337,854
BioCentury | Oct 15, 2024
Management Tracks
Rubin leaving Boundless as CFO, new CSOs for C4, Avacta and Commit
Plus: David Cameron named chair of Oxford-Harrington Rare Disease Centre’s advisory council, and updates from Twist, Boundless, Lucy and more
BioCentury | Apr 30, 2024
Management Tracks
Innovent hires Gracell vet Samuel Zhang as CBO
Plus: CEO changes at Lexicon, Avacta and Sphere Fluidics, and updates from Generate, Charm, ViaNautis and more
BioCentury | Apr 12, 2024
Product Development
Cambrian explosion of ADCs at AACR24
Conference showcases six emerging ADC payload types, and trends in antigen pairs for bispecific ADCs
BioCentury | Dec 21, 2023
Management Tracks
Larson leaving LianBio as CFO
Plus: Claypoole becomes CEO of Bioventus, and updates from Boston Pharma, Atlas, Quest, Scribe, 858 and more
BioCentury | Sep 14, 2023
Management Tracks
DNAnexus names Laur as CEO
Plus: Ports now CSO at Cargo and updates from Protalix, Culture, 4D, DiaMedica, Likarda, Precise, Pixelgen and Oviva
BioCentury | May 18, 2023
Management Tracks
Roche’s Perettie to head cell therapy at Kite
Plus: Ochre appoints Forster as chairperson and updates from Women In Bio, Verismo and MIG
BioCentury | Mar 28, 2023
Management Tracks
New strategy heads at Genmab and Codagenix
Plus: OncoVerity names Colao CEO and Smith CMO, and updates from Silence, Mannkind, Immuneering and more
BioCentury | Sep 3, 2021
Management Tracks
Civetta picks Roberts as CEO
Plus, management moves at Crinetics, OraSure, Silence, Avacta, Oncternal and more
BioCentury | Jul 3, 2021
Translation in Brief
Timing TREM2 intervention in Alzheimer’s; plus Regeneron, Avacta and Atomwise
BioCentury’s roundup of translational news
BioCentury | Jun 3, 2021
Product Development
ASCO21 data for bispecific checkpoints bode well for coming wave of therapies
As pipeline grows, early clinical readouts report at ASCO21
Items per page:
1 - 10 of 29